Childhood and adolescent cancer diagnosis, treatment, and hospitalizations during the COVID-19 pandemic in Quebec, Canada, a population-based study

The COVID–19 pandemic disrupted healthcare delivery globally. In Quebec, Canada, measures were introduced to prioritize pediatric oncology care. Using administrative data, we estimated pandemic-related changes in cancer diagnoses, treatments, and length of hospital stay among individuals aged 0–19 in Quebec (2015–2023). Interrupted time series analyses using autoregressive integrated moving average (ARIMA) models assessed immediate and sustained changes in monthly age-standardized rates of diagnoses, treatments (chemotherapy, surgery, radiotherapy-related encounters), positron emission tomography scans, and hospital admissions. Separate ARIMA models fitted to pre-pandemic monthly counts generated counterfactual forecasts to estimate the cumulative differences between observed and expected diagnoses and treatments over 3, 12, and 46 months of the pandemic. Generalized linear mixed models assessed changes in length of stay between the pre- and post-pandemic periods and whether these changes differed by patient characteristics. We identified 2,570 patients: 1,475 diagnosed through February 2020 and 1,095 from March 2020 onward. We found no evidence of immediate or sustained changes in monthly incidence rates. Cumulative diagnoses and treatments remained within expected levels across periods, although estimates were imprecise. For diagnoses, the 3−, 12−, and 46−month cumulative differences were −1 (95% uncertainty interval [UI] −17 to 15), 24 (95% UI, −9 to 57), and 2 (95% UI, −94 to 96), respectively. Changes in length of hospital stay varied across subgroups, although their clinical significance remains uncertain. Pediatric cancer diagnosis and treatment activity was largely maintained across Quebec throughout the pandemic, consistent with the objectives of provincial and institutional measures to preserve pediatric oncology services.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.18.26367724
Primary Topic
COVID-19 and healthcare impacts
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Childhood and adolescent cancer diagnosis, treatment, and hospitalizations during the COVID-19 pandemic in Quebec, Canada, a population-based study

Hallie Coltin, Talía Malagón, Mariam El‐Zein, Ronald Barr et al.
3 links
medRxiv
COVID-19 and healthcare impacts
preprint

Childhood and adolescent cancer diagnosis, treatment, and hospitalizations during the COVID-19 pandemic in Quebec, Canada, a population-based study

Hallie Coltin, Talía Malagón, Mariam El‐Zein, Ronald Barr, Erin STRUMPF, Callum Mullen, Eduardo Franco
preprint en

Abstract

The COVID–19 pandemic disrupted healthcare delivery globally. In Quebec, Canada, measures were introduced to prioritize pediatric oncology care. Using administrative data, we estimated pandemic-related changes in cancer diagnoses, treatments, and length of hospital stay among individuals aged 0–19 in Quebec (2015–2023). Interrupted time series analyses using autoregressive integrated moving average (ARIMA) models assessed immediate and sustained changes in monthly age-standardized rates of diagnoses, treatments (chemotherapy, surgery, radiotherapy-related encounters), positron emission tomography scans, and hospital admissions. Separate ARIMA models fitted to pre-pandemic monthly counts generated counterfactual forecasts to estimate the cumulative differences between observed and expected diagnoses and treatments over 3, 12, and 46 months of the pandemic. Generalized linear mixed models assessed changes in length of stay between the pre- and post-pandemic periods and whether these changes differed by patient characteristics. We identified 2,570 patients: 1,475 diagnosed through February 2020 and 1,095 from March 2020 onward. We found no evidence of immediate or sustained changes in monthly incidence rates. Cumulative diagnoses and treatments remained within expected levels across periods, although estimates were imprecise. For diagnoses, the 3−, 12−, and 46−month cumulative differences were −1 (95% uncertainty interval [UI] −17 to 15), 24 (95% UI, −9 to 57), and 2 (95% UI, −94 to 96), respectively. Changes in length of hospital stay varied across subgroups, although their clinical significance remains uncertain. Pediatric cancer diagnosis and treatment activity was largely maintained across Quebec throughout the pandemic, consistent with the objectives of provincial and institutional measures to preserve pediatric oncology services.

medRxiv
Centre Hospitalier Universitaire Sainte-Justine (CA), McGill University (CA), McMaster University (CA)
McGill University, Réseau de cancérologie Rossy, Canadian Institutes of Health Research
Good health and well-being
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon